Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
immunosuppressant |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L04AD02
|
| gptkbp:brand |
gptkb:Astagraf_XL
gptkb:Envarsus_XR |
| gptkbp:form |
gptkb:tacrolimus
|
| https://www.w3.org/2000/01/rdf-schema#label |
tacrolimus extended-release
|
| gptkbp:indication |
kidney transplant rejection prevention
liver transplant rejection prevention |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
immunosuppressant
|
| gptkbp:metabolism |
gptkb:CYP3A4
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
hypertension
tremor nephrotoxicity hyperglycemia |
| gptkbp:usedFor |
prevention of organ transplant rejection
|
| gptkbp:bfsParent |
gptkb:Astagraf_XL
gptkb:Envarsus_XR |
| gptkbp:bfsLayer |
7
|